21 Jul 2017 | CannaTech News
We've all heard of THC and CBD and the many benefits of consuming each, but have you ever heard of CBN (cannabinol)?
19 Jul 2017 | Leafly
The fear of being labeled a "stoner" can make some patients leave painful symptoms untreated. Others may avoid the doctor entirely.
19 Jul 2017 | CannaTech News
With autoimmune disorders on the rise and standard treatments rendered ineffective, it might be time to look for an alternative solution, such as CBD
16 Aug 2017 | Cashinbis
The National Institutes of Health awarded a $3.8 million grant to Albert Einstein College of Medicine and Montefiore Health System last week.
7 Jul 2017 | Nature
The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC).
8 Aug 2017 | MarketWatch
GW Pharma’s Epidiolex could be the U.S.’s first cannabis-derived drug.
6 Jul 2017 | National Institute of Standards and Technology
NIST researchers have measured a fundamental physical property of the primary psychoactive compound in marijuana.
1 Jul 2017 | CannaTech News
Studies are increasingly suggesting that CBD could be the next vital medicine for a whole host of human medical conditions
30 Jun 2017 | Science Alert
A new study has investigated what patients themselves prefer when it comes to managing pain – opioids, which are widely distributed for intense pain relief, or medical marijuana.
29 Jun 2017 | Civilized
A pioneering study out of Pennsylvania will explore the effect of cannabis on children with autism. Researchers from Lehigh University plan to partner with a potential grower in the Lehigh Valley to collect quantitative data on cannabis therapy for autism.